Demonstrator projectsNewsUncategorized REMEDi4ALL hosts first Multi-Stakeholder Meeting on Pancreatic Cancer Pancreatic cancer, a rare and hard to treat type of cancer, is one of four…tools@teamitresearch.com12 December 2023
Funders International Funders Network established A worldwide network of funders focusing on drug repurposing has been established under the leadership…tools@teamitresearch.com9 November 2023
News EATRIS and the REMEDi4ALL Consortium to Initiate New Study to Advance Potential Treatment for Ultra-Rare Disease Tazarotene, originally approved as a topical cream for psoriasis and acne, will be investigated as…admin13 October 2023
Resources REMEDi4ALL Concierge: Connecting with the drug repurposing community The primary objective of the REMEDi4ALL Concierge is to actively engage with the repurposing community,…Piret Baur28 September 2023
Uncategorized REMEDi4ALL General Assembly Meeting brings together over 100 participants to discuss roadmap ahead The second REMEDi4ALL General Assembly meeting took place in Amsterdam last June 26-27. Around 100 participants representing…tools@teamitresearch.com27 September 2023
Demonstrator projects First Patients Recruited in a Repurposing Clinical Trial Funded Through REMEDi4ALL Image: Alfredo Boudillon, Scientific Director of Institution Pascale Institute Pascale, a renowned comprehensive cancer centre…Piret Baur14 September 2023
Funders REMEDi4ALL’s first workshop for funders on Innovating drug repurposing Over 50 representatives from (non-) governmental funders, philanthropies and pharmaceutical companies from around the world…Piret Baur13 September 2023
Rare Diseases Rick Thompson on involving patients directly in creating impactful medicines Why is it that in drug development, the needs and preferences of those who are…Piret Baur8 September 2023
Rare Diseases EVE SCOTT: RARE DISEASE DAY, A PATIENT-LED COMMUNITY Please tell us a bit about yourself. I joined Beacon in October 2022 as Senior…Ivette Corominas27 February 2023
Rare Diseases CLAUDIA FUCHS: RARE DISEASE DAY IS A GLOBAL VOICE Please tell us a bit about yourself. I joined EURORDIS in September 2022 as part…Ivette Corominas22 February 2023
Rare Diseases RICK THOMPSON: RARE DISEASE DAY SHOWS A DETERMINED COMMUNITY Please tell us a bit about yourself. I’m the CEO of Beacon, formerly an evolutionary…Ivette Corominas15 February 2023
News Horizon Magazine highlights the innovative potential of drug repurposing , Horizon Magazine published an article on drug repurposing featuring REMEDi4ALL project. According to the…Ivette Corominas30 November 2022
News EURORDIS introduces REMEDi4ALL in an interview with Pharmaceutiques Virginie Hivert, Director of Therapeutic Development at Eurordis, was recently interviewed by PhamaceutiquesIvette Corominas30 November 2022
News Pancreatic Cancer Awareness Day: “Safe and effective therapies are urgently needed to fight Pancreatic Cancer” Every year, approximately 140.000 people are diagnosed with pancreatic cancer in Europe. This is one…Ivette Corominas17 November 2022
News REMEDi4ALL takes off in Amsterdam! The iconic building The Eye in central Amsterdam, welcomed the REMEDi4ALL Consortium last September for…Gisela Pairo4 November 2022
News New publication on drug repurposing by Fiocruz – member of REMEDi4ALL Policy Board Researchers from Oswaldo Cruz Foundation - Fiocruz - in Brazil, have published a paper on…Piret Baur28 October 2022
News 📣 Calling to all research funders willing to advance Drug Repurposing! REMEDi4ALL has just launched a call inviting research funders to share their experience and ideas…Gisela Pairo28 October 2022
News REMEDi4ALL, an ambitious EU-funded research initiative, launches today to drive forward the repurposing of medicines in Europe REMEDi4ALL, an ambitious EU-funded research initiative, launches today to drive forward the repurposing of medicines…admin1 September 2022
News International partnership dedicated to repurposing of medicines is launched The repurposing of existing medicines has the potential to greatly improve public health outcomes, especially on neglected and rare…admin24 August 2022
News Existing drugs block or reduce SARS-CoV2 infection in cells Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat…admin18 August 2022